The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Malignant Hyperthermia Association of the United States
1 North Main St
PO Box 1069
Sherburne, NY 13460
The Malignant Hyperthermia Association of the United States (MHAUS) is a non-profit, voluntary organization dedicated to reducing morbidity and mortality from malignant hyperthermia (MH). It seeks to improve the medical care of people susceptible to malignant hyperthermia and provide support information for people with this uncommon disorder. It also seeks to improve scientific understanding of MH and promote ongoing medical research on this disorder and related ones. Educational materials produced by MHAUS include brochures; a booklet, "Understanding MH"; an in-service video; a quarterly newsletter; MH procedure manuals for hospital and office-based surgeries; and a directory of MH muscle biopsy and molecular genetic testing locations in North America.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.